Considerations for shared decision management in previously untreated patients with hemophilia A or B.

"The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: JA has received research grants from Sobi, CSL Behring, Takeda/Shire, and Bayer, and speaker’s fees and consultancy for Octapharma, Novo Nordisk, Pfizer, Bayer, Sobi, CSL Behring, Takeda/Shire, BioMarin, UniQure, and Spark Therapeutics. JB has received speaker’s fees and/or consultancy for Sobi, Roche, Novo Nordisk, and Takeda. CK has received speaker’s fee or advisory honoraria from Bayer, CSL Behring, Novo Nordisk, Roche/Chugai, Sobi/Sanofi, and Takeda, and research funding to the university from Bayer, Biotest, CSL Behring, Intersero, Novo Nordisk, Pfizer, Sobi/Sanofi, and Takeda. CH has received reimbursement for attending symposia/congresses and/or honoraria for speaking and/or honoraria for consulting, and/or funds for research from Pfizer, Takeda/Shire, Bayer, Biomarin, Sanofi, CSL Behring, Grifols, Novo Nordisk, Sobi, Roche, Octapharma, LFB, UniQure, Freeline Therapeutics, and Spark Therapeutics. VJ-Y has received reimbursement for attending symposia/congresses and/or honoraria for speaking and/or honoraria for consulting, and/or funds for research from Takeda, Bayer, Biomarin, Sanofi, CSL Behring, Grifols, Novo Nordisk, Sobi, Roche, Octapharma, and Pfizer. DPH has received research grants and/or clinical trial activity and departmental income from Bayer, Biomarin, Sobi, Sigilon, Octapharma, Takeda, and UniQure, as well as speaker’s fees/advisory honoraria from Bayer, Biomarin, Biotest, CSL Behring, Grifols, LFB, Novo Nordisk, Octapharma, Pfizer, Roche, Sanofi, Spark, Sobi, Takeda, and UniQure."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This review article is the outcome of the scientific project (FVIII Think Tank, renamed Factor Think Tank) funded by Sobi; the current members of the Factor Think Tank group are listed in the Supplemental Appendix ."